JESSICA HERNANDEZ: Open Payments
NPI 1962166504 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,458 in 121 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $268 · 2025 $3,458
Food & beverage: $3,458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $745 |
| PFIZER INC. | 16 | $418 |
| Janssen Biotech, Inc. | 16 | $396 |
| Madrigal Pharmaceuticals | 10 | $370 |
| Regeneron Healthcare Solutions, Inc. | 8 | $287 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $225 |
| Phathom Pharmaceuticals, Inc. | 8 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $183 |
| Celltrion USA Inc. | 8 | $151 |
| Ardelyx, Inc. | 4 | $132 |
Products named: TREMFYA, REZDIFFRA, XELJANZ, DUPIXENT, XIFAXAN, VOQUEZNA, LINZESS, VEGZELMA.
Industry payments across TN — which companies pay providers there.
